Publication: Statistical methods for polygenic risk prediction from biobanks and genome-wide association studies
Open/View Files
Date
Authors
Published Version
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
Citation
Abstract
Polygenic risk scores (PRS) have emerged as a promising tool to translate genomic discoveries into clinic decision making. By aggregating the effects of risk-associated genetic variants across the genome into a single number, PRS can quantify a patient’s genetic predisposition for a wide range of health outcomes. The past decade has seen an explosion of statistical methodology to build PRS prediction models, but these existing methods face limitations in prediction accuracy, computational efficiency, and generalizability across populations. In this dissertation, we present three novel approaches to tackle these challenges.
In Chapter 1, we propose ALL-Sum, an ensemble learning-based PRS method that uses summary statistics from genome-wide association studies (GWAS). ALL-Sum leverages L0L2-penalized regression and fast optimization algorithms to enable high prediction accuracy while also dramatically reducing the computational runtime and memory usage. Then, in Chapter 2, we propose SPLENDID, which models gene-by-ancestry interactions to simultaneously capture shared and heterogeneous genetic effects without categorizing individuals into discrete ancestry groups, allowing for fairer clinical implementation in diverse patient populations. Finally, in Chapter 3, we propose STELLAR, which ensembles multiple prediction modeling approaches and functional genomic annotations to flexibly estimate rare variant effects for more comprehensive genome-wide PRS.
Altogether, the work from this dissertation introduces new statistical frameworks to efficiently compute accurate PRS from large-scale genomic data. Each method demonstrates substantial improvements over the current state-of-the-art through comprehensive simulation studies and application to real data. These tools can be used to develop new prediction models for complex traits and diseases and ultimately advance precision medicine.